GSK plc (GSK)
LSE
1,877.50
-22.50 (-1.18%)
Closed
Sep 18, 2026
Day's Range
1,852.501,912.00
52 wk Range
17.232,282.00
Financial Statements - GSK - GSK plc
Revenue
32.66B▲ 4.1%
Net Income
6.28B▲ 113.1%Net Margin 19.3%
EBITDA
10.70B▲ 31.7%
Free Cash Flow
4.75B▲ 33.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 32.66B | 31.37B | 30.32B | 29.32B | 24.69B | 24.35B |
| Cost of Goods | 9.01B | 9.04B | 8.56B | 9.55B | 8.16B | 7.92B |
| Gross Profit | 23.65B | 22.32B | 21.76B | 19.77B | 16.53B | 16.42B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 8.33B | 5.54B | 7.34B | 6.72B | 4.87B | 4.57B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 7.40B | 3.47B | 6.06B | 5.62B | 3.59B | 5.17B |
| Income Tax | 1.11B | 526M | 756M | 707M | 83M | 67M |
| Net Income | 6.28B | 2.95B | 5.30B | 15.62B | 5.09B | 6.38B |
| EPS Basic | 1.411 | 0.632 | 1.216 | 3.714 | 1.095 | 1.44375 |
| EPS Diluted | 1.388 | 0.622 | 1.199 | 3.662 | 1.0825 | 1.42625 |
| Basic Shares Outstanding | 4.05B | 4.07B | 4.05B | 4.02B | 4B | 3.98B |
| Diluted Shares Outstanding | 4.05B | 4.07B | 4.05B | 4.02B | 4B | 3.98B |
| Ebit | 8.08B | 4.11B | 6.78B | 6.45B | 4.36B | 6.01B |
| Ebitda | 10.70B | 8.12B | 9.62B | 8.87B | 7.04B | 6.65B |
| Net Income Continuous Operations | 6.28B | 2.95B | 5.30B | 4.92B | 3.51B | 5.10B |
| Minority Interests | -573M | -376M | -380M | -665M | -711M | -639M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
